The Centers for Disease Control and Prevention Friday announced a plan for ensuring a continuous supply of yellow fever vaccine for travelers to countries where the virus is endemic or epidemic. Supplies of the only U.S.-licensed vaccine are expected to run out soon due to recent manufacturing problems. Until domestic production of the vaccine can resume in 2018, public health officials have arranged to import a yellow fever vaccine as an investigational new drug for distribution at a limited number of sites. In 2015, about 8 million U.S. residents traveled to 42 countries in Africa and South America where the virus is endemic. While most infected people have no symptoms, about 15% will develop severe disease. CDC expects to provide updates on the vaccine shortage at https://wwwnc.cdc.gov/travel.

Related News Articles

Headline
The Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response tomorrow will host a webinar on lessons…
Headline
Health and Human Services Acting Secretary Eric Hargan yesterday declared a public health emergency in California due to the wildfires devastating the…
Headline
The California Hospital Association and its regional partners have established a Hospital Workers’ Fire Relief Fund to help the more than 100 hospital…
Headline
Baxter Healthcare Corp., in coordination with the Food and Drug Administration, has agreed to temporarily import certain intravenous drug products, such…
Headline
At least two hospitals evacuated patients yesterday due to the wildfires in northern California. Kaiser Permanente transported about 130 patients from Santa…
Headline
Health and Human Services Acting Secretary Don Wright, M.D., yesterday declared public health emergencies in Alabama, Florida, Louisiana and Mississippi due to…